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Abstract Background: Point prevalence studies identify that pneumonia is the most common
healthcare associated infection. However, non-ventilator associated healthcare associated
pneumonia (NV-HAP) is both underreported and understudied. Most research conducted to
date, focuses on ventilator associated pneumonia. We conducted a systematic review, to pro-
vide the latest evidence for strategies to reduce NV-HAP and describe the methodological ap-
proaches used.
Methods: We performed a systematic search to identify research exploring and evaluating NV-
HAP preventive measures in hospitals and aged-care facilities. The electronic database Med-
line was searched, for peer-reviewed articles published between 1st January 1998 and 31st
August 2018. An assessment of the study quality and risk of bias of included articles was con-
ducted using the NewcastleeOttawa Scale.
Results: The literature search yielded 1551 articles, with 15 articles meeting the inclusion
criteria. The majority of strategies for NV-HAP prevention focussed on oral care (nZ 9). Three
studies evaluated a form of physical activity, such as passive movements, two studies used
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dysphagia screening and management; and another study evaluated prophylactic antibiotics.
Most studies (nZ 12) were conducted in a hospital setting. Six of the fifteen studies were ran-
domised controlled trials.
Conclusion: There was considerable heterogeneity in the included studies, including the type
of intervention, study design, methods and definitions used to diagnose the NV-HAP. To date,
interventions to reduce NV-HAP appear to be based broadly on the themes of improving oral
care, increased mobility or movement and dysphagia management.
ª 2019 The Authors. Published by Elsevier B.V. on behalf of Australasian College for Infection
Prevention and Control. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Highlights
 There is considerable heterogeneity in the study design, interventions, methods and defi-
nitions used in NV-HAP studies.
 Improving oral care, increased mobility or movement and dysphagia management appear to
be key strategies in reducing NV-HAP.
 Further research in a hospital setting, using robust designs are needed.
Introduction
In recent years, there have been numerous initiatives to
reduce certain healthcare-associated infections (HAIs),
such as bloodstream infections [1], urinary tract infections
[2] and surgical site infections [3]. In some countries, there
have also been government targets, incentives and pen-
alties for specific HAIs, including central line-associated
bloodstream infections, catheter-associated urinary tract
infections, surgical site infections (colon and hysterec-
tomy), methicillin-resistant Staphylococcus aureus bacter-
emia and Clostridium (Clostridioides) difficile infections
[4]. However, despite hospital-acquired pneumonia (HAP)
reported as one of the most common HAIs [5e7], this
infection has received little attention to date.
Point prevalence studies (PPS) in Europe and the United
Stateshighlight the typeandproportionofdifferentHAIs.Data
from Europe identified HAP as the most frequent HAI in prev-
alence studies conducted in England, Northern Ireland, Scot-
land, Wales [6] and Switzerland [8]. In 2015, a multi-site PPS
conducted in the United States also identified pneumonia as
themostcommonHAI,withaprevalenceof26%[5].Thirty-five
percent of the pneumonia cases were classified as ventilator-
associated pneumonia (VAP) and 65% as non-ventilator-
associated hospital-acquired pneumonia (NV-HAP) [5], the
twosubcategoriesofHAP.AcommondefinitionofVAPiswhere
a case of pneumonia where the patient is on mechanical
ventilation for>2 calendar days on the date of event and the
ventilator was in place on the date of event or the day before,
other cases being considered NV-HAP [9].
While the impact of both VAP and NV-HAP on healthcare
services and patients is significant, evidence suggests that
NV-HAP occurs more frequently, is associated with higher
healthcare costs and is equally as dangerous as VAP [10].
Findings from a multi-centred study from the United States
suggests that 18.8% of patients with NV-HAP required
transfer into the intensive care unit [11]. NV-HAP also re-
sults in a prolonged hospital stay and increased patient
morbidity and mortality [12,13]. However, NV-HAP is both
underreported and understudied with most research con-
ducted on VAP, thereby prompting recent calls for an ur-
gent need to prioritise research on NV-HAP [14]. This paper
therefore focuses on NV-HAP, rather than VAP.
Risk factors for the development of NV-HAP are quite
varied and similar to those for HAP in general [14]. Some
identified risk factors include age (>70 years), male sex,
length of hospital stay, multiple comorbidities, dysphagia
and chronic obstructive pulmonary disease [12,15e17]. In
some cases, patients may also present with few to no risk
factors [14]. Poor oral hygiene associated with dental pla-
que build up has also been identified as an important risk
factor [18], with identical genetic profiles found between
respiratory pathogens isolated from dental plaque and
bronchoalveolar lavage fluid [19]. Various studies have
demonstrated the benefits of implementing comprehensive
oral care management protocols in reducing the incidence
of NV-HAP [14,20e22], highlighting the potential health and
financial gains that could result from widespread imple-
mentation of such strategies for this problematic HAI
[16,23]. Previous reviews have indicated that interventions
that target potential modifiable risk factors may reduce NV-
HAP, including improved oral hygiene, hand hygiene, early
mobilisation, identification and appropriate management
of dysphagia particularly in post-stroke patients, and pre-
vention of viral infections [16,23]. We present a contem-
porary review, which seeks to provide the latest evidence
for strategies to reduce NV-HAP and describe the method-
ological approaches used. Based on this, we will present
key gaps in the literature and methodological consider-
ations to inform future interventional studies.
Methods
A systematic review to identify research exploring and
evaluating NV-HAP preventive measures in hospitals and
aged-care facilities was undertaken. Reporting of this sys-
tematic review complied with the preferred reporting
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items for systematic reviews and meta-analyses (PRISMA)
guidelines [24].
Search strategy
We performed a systematic search of the literature. Using
the key words stated below, we searched the electronic
database Medline and reviewed the reference lists of
eligible articles to identify any additional relevant articles.
The electronic search was limited to articles published
between 1st January 1998 and 31st August 2018 in peer-
reviewed journals, with no limits placed on language. A
combination of Medical Subject Heading (MeSH) and free-
text terms was used, based on a prior review of the liter-
ature [16].
The first search involved the following terms: (‘pneu-
monia’ OR ‘respiratory tract infection’ OR ‘respiratory
infection’) AND (‘nosocomial’ OR ‘hospital-acquired’ OR
‘healthcare associated’ OR ‘healthcare-associated’) AND
(‘prevention’). We performed an additional search and
combined this with the results from the previous search.
The keywords used in the second search were (‘pneu-
monia’ OR ‘respiratory tract infection’ OR ‘respiratory
infection’) AND (‘nosocomial’ OR ‘hospital-acquired’ OR
‘healthcare associated’ OR ‘healthcare-associated’) AND.
 ‘hand hygiene’ OR ‘hand washing’ OR
 ‘oral care’ OR ‘oral hygiene’ OR ‘oral decontamination’
OR ‘oral health’ OR ‘mouthwashes’
 ‘bed position’ OR ‘head position’ OR ‘body position’ OR
‘bed rest’ OR ‘bed protocol’
 ‘mobilization’ OR ‘mobility’ OR ‘motility’ OR ‘physical
activity’ OR ‘physiotherapy’
 ‘dysphagia’ OR ‘swallowing’ OR ‘swallowing disorder’ OR
‘aspiration’ OR ‘aspirative’
 ‘viral infection’ OR ‘viral’ OR ‘virus’ OR ‘flu’
 ‘stress bleeding prophylaxis’ OR ‘gastric’ OR ‘gastric
protection’ OR ‘acid-suppressive therapy’ OR ‘acid-sup-
pressive’ OR ‘proton pump inhibitor’ OR ‘omeprazole’
OR ‘ranitidine’
Selection criteria
The inclusion criteria were all randomised controlled trials
and observational studies (cohort, case control, observa-
tional, cross sectional or case/short reports) that exam-
ined measures (excluding vaccination and systematic
antimicrobial therapy) to reduce HAP in hospitals and
aged-care facilities. Only studies examining adult pop-
ulations were included. Studies that did not analyse the
effect of any prevention measure were initially included
but subsequently removed for sub-analysis. Exclusion
criteria were studies examining VAP, all grey literature,
non-peer-reviewed literature, reviews, editorials and
commentaries.
Definitions
For the purpose of this systematic review, we used the
following definitions:
 ‘Healthcare-associated infection’ refers to any infection
as defined or accepted by the authors as being
healthcare-associated, hospital-acquired or nosocomial.
 ‘Measure’ refers to interventions, clinical practice or
policy. It excludes systematic antimicrobial treatment
and vaccination measures.
 We accepted the definitions and application of defining
pneumonia as stated in the paper.
Study selection
We examined and assessed the titles and abstracts of all
the publications identified in the electronic database for
relevance and appropriateness to the review question
and excluded those that were irrelevant. Of the
remaining articles, we reviewed the full texts to assess
their further eligibility. Articles deemed to have data
relevant to the systematic review were included. Trained
research assistants performed the study selection process
and other stages of the review. Ten percent of the orig-
inal articles were cross-checked with the study eligibility
criteria by two of the research assistants. In addition, an
experienced research member randomly selected 10% of
the original articles retrieved in the initial search and
reviewed them as a cross-check against the study eligi-
bility criteria. Two members of the research team
resolved any discrepancies that were observed in the
application of either the inclusion or the exclusion
criteria.
Data extraction
For each eligible study, the following data were extracted
using a data extraction form developed in Excel (Microsoft,
USA): author(s); year of publication; country of study; study
design; study population; sample; setting; outcome mea-
sures; results for both the control and intervention groups,
and conclusions. All data extracted were cross-checked by
a second member of the team. We did not attempt to
contact the authors of papers that contained missing data
or unclear information.
Risk of bias
An assessment of the study quality and risk of bias in the
articles included in the review was conducted using the
NewcastleeOttawa Scale [25,26]. The NewcastleeOttawa
Scale, is a collaboration between several universities, to
assess the quality of studies with its design, content and
ease of use directed to the task of incorporating the quality
assessments. The scales uses a ‘star system’ to judge arti-
cles in three broad perspectives: the selection of the study
groups; the comparability of the groups; and the ascer-
tainment of either the exposure or outcome of interest for
case-control or cohort studies respectively [27]. A
maximum of nine stars to be awarded to a study. The
content validity and inter-rater reliability of this tool have
been established [26]. One researcher undertook this
assessment independently, with a random 10% of the arti-
cles reviewed by a second researcher. There were no
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discrepancies in the application of the risk of bias assess-
ment found, when the random sample of articles was
compared by a second reviewer.
Data analysis
Extracted data from the included studies were synthesised
and summarised in evidence tables. Given the significant
heterogeneity in the included studies, we did not attempt
to conduct a meta-analysis.
Results
Overview
The literature search yielded 1551 articles. Of these, 56
articles remained for a full text review following a review
of the titles and abstracts and the exclusion of duplicates.
After screening the 56 articles against the study’s inclusion
and exclusion criteria, we excluded 43 articles either
because they did not report on NV-HAP, they did not eval-
uate the impact of an intervention, or they were reviews.
With the addition of three eligible articles that were known
to the research team from manual searches (one from an
excluded review, two from references lists of included ar-
ticles), 15 articles met the inclusion criteria and were
included in the final systematic review (Fig. 1).
In this review of literature, we identified 15 studies that
involved an intervention aimed at reducing NV-HAP. There
was considerable heterogeneity in these studies, including
the type of intervention, study design, methods and defi-
nitions used to diagnose the NV-HAP. To date, interventions
to reduce NV-HAP appear to be based broadly on the
themes of improving oral care, increased mobility or
movement and dysphagia management.
Study characteristics
Table 1 provides an overview of the 15 studies included in
the review. The majority of strategies for NV-HAP preven-
tion focussed on oral care (n Z 9), with four oral care ap-
proaches using dental professionals [28e31]. Three studies
evaluated a form of physical activity, such as passive
movements [32e34]; two studies used dysphagia screening
and management [35,36]; and another study evaluated
prophylactic antibiotics [37]. Most studies (n Z 12) were
conducted in a hospital setting. Six of the fifteen studies
were randomised controlled trials.
Risk of bias assessment
We undertook a risk of bias assessment on the 15 studies
included in the review. The maximum star rating using the
NewcastleeOttawa Scale is nine stars. Four studies
received a star rating of eight [31,36e38], six studies
received a rating of seven [20,29,32e34,39] and five studies
received a rating of five or less [14,28,30,35,40]. Table 2
provides an overview of the risk of bias assessment for
each study.
Figure 1 Flow diagram for selection of articles.
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Table 1 Studies included in the review.
Author, Year Design Sample Setting Broad intervention
strategy
Significant change in pneumonia
Adachi et al., 2002 [28] RCT 141 Nursing home Oral care (professional) YES
Bellisimo-Rodrigues et al., 2014 [29] RCT 254 Hospital
(Intensive Care Unit)
Oral care (professional) YES
Boden et al., 2018 [32] RCT 441 Hospital Physical activity YES
Bouringault et al., 2010 [30] RCT 2513 Nursing home Oral care (professional) NO
Chen et al., 2016 [40] Cohort 873 Hospital
(Intensive Care Unit)
Oral care YES
Cuesy et al., 2010 [33] RCT 223 Hospital Physical activity YES
Johansen et al., 2016 [37] Cohort 88 Hospital
(Ear, Nose and
Throat Department)
Prophylactic antibiotics YES
McNally et al., 2018 [38] Quasi-experimental 2891 Hospital (non-ICU) Oral care NO
Quinn et al., 2014 [14] Quasi-experimental Hospital Oral care Decreaseþ
Robertson et al., 2013 [20] Quasi-experimental 85 Hospital
(acute neurosurgical
unit)
Oral care YES
Schrock et al., 2018 [35] Cohort 2372 Hospital Dysphagia screen YES
Stolbrink et al., 2014 [34] Quasi-experimental 156 Hospital
(respiratory and
elderly wards)
Physical activity YES
Titsworth et al., 2013 [36] Cohort 2334 Hospital Dysphagia screen YES
Wagner et al., 2016 [39] Cohort 1656 Hospital Oral care YES
Yoneyama et al., 2012 [31] RCT 366 Nursing Home Oral care (professional) NO
Note: þ significance values not provided.
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Oral care and NV-HAP prevention
Nine studies in this review involved an oral care interven-
tion to reduce the incidence of NV-HAP. Four of the nine
studies involved professional oral care, such as oral care
provided by a dentist or hygienist. All of these studies were
randomised controlled studies [28e31], and three of them
were performed in nursing homes [28,30,31]. The
remainder of the studies (n Z 5), did not use professional
dental care as part of the oral care intervention
[14,20,38e40]. None of these five studies used a rando-
mised controlled design.
Non-professional oral care
There was considerable heterogeneity among interventions
in the studies that involved routine oral care (i.e. non-
professional dental care). No two studies had the same
intervention, and where an antiseptic was used as part of
oral care, the type of antiseptic differed between studies.
The interventions included: oral care kits that contained an
antiseptic (cetylpyridinium chloride and 1.5% hydrogen
peroxide) [39]; oral care by swabbing with an antiseptic
(chlorhexidine gluconate vs. metronidazole) [40]; increased
volume of oral care and the use of an antiseptic (0.05%
cetylpyridinium chloride) [38]; oral care kits and the use of
a toothbrush containing sodium bicarbonate and an anti-
septic (antiseptic unspecified) [14]; and moisturiser,
toothbrushes and oral swabs impregnated with sodium bi-
carbonate and an antiseptic rinse (1.5% hydrogen peroxide)
[20]. The outcomes from the oral care interventions were
largely associated with a reduction in NV-HAP (Table 3).
Professional oral care
Four studies involved the use of a dentist or dental hy-
gienist in the delivery of oral care [28e31]. The in-
terventions in the studies included.
 Dental hygienists performed professional oral health
care weekly [28]
 dental care provided by a dental surgeon, 4e5 times a
week [29] Patients receiving dental care were compared
to those receiving routine oral care.
 annual visit to the dentist, tooth, tongue and mucosa
brushing three times a day and after each meal [30] In
addition, those receiving the intervention received used
an chlorhexidine mouth wash.
 annual visit to the dentist, tooth, tongue and mu-
cosa brushing three times a day and after each
meal [31]
Two of the four studies identified a reduction in NV-HAP
associated with the intervention (Table 3) [28,31]. One
study recorded no cases of NV-HAP during the intervention
phase [29], while the fourth and largest study did not
identify a reduction in NV-HAP [30].
Dysphagia and NV-HAP prevention
Two non-randomised studies used dysphagia screening as
the primary method for NV-HAP prevention [35,36].
Schrock and colleagues used a pre-post quasi-experi-
mental study to evaluate rates of NV-HAP in patients with
ischemic and haemorrhagic stroke both before and after
the use of a dysphagia screen [35]. In the post study
phase, a dysphagia screening test was applied to all
acute stroke patients in the emergency department. For
patients In the haemorrhagic group, the incidence of NV-
HAP decreased from 19% to 15% (P < 0.001), while in the
ischemic stroke groups, NV-HAP rates decreased from
13.8% to 8% (P Z 0.007) [35]. Titsworth et al. also
examined an intervention in patients with ischemic or
haemorrhagic stroke [36]. The intervention was a nurse-
led bedside dysphagia screen and a rapid clinical swal-
low undertaken by a speech pathologist. The authors
suggest that this quality improvement initiative coincided
with a reduction in NV-HAP from 6.5% to 2.8% among the
stroke patients (P < 0.001) [36].
Table 2 Risk of bias assessment.
First Author Year Elements of NewcastleeOttawa Scale
Selection (0e4) Comparability (0e2) Exposure (0e3) Total stars
Adachi 2002 4 0 0 4
Bellisimo-Rodrigues 2014 2 2 3 7
Boden 2018 2 2 3 7
Bourigaulta 2010 4 1 0 5
Chen 2016 3 0 2 5
Cuesy 2010 3 1 3 7
Johansen 2016 3 2 3 8
McNally 2018 3 2 3 8
Quinn 2014 2 0 3 5
Robertson 2013 4 0 3 7
Schrock 2018 3 0 2 5
Stolbrink 2014 3 2 2 7
Titsworth 2013 4 2 2 8
Wagner 2016 3 2 2 7
Yoneyama 2002 4 1 3 8
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Table 3 Summary of findings involving oral care and healthcare associated pneumonia.
Study (first author) Outcome Intervention (n) Control (n) Comments
Event Total Event Total
Professional dental care
Adachi Fatal aspiration pneumonia 2 40 8 48 Significant reduction (p < 0.05). Original sample Z 141,
participants lost to follow-up. Observed over 24 month period.
Bellisimo-Rodrigues Pneumonia in
non-ventilated patients
0 127 1 127 No cases during intervention. 294 sample, 40
excluded as died or discharged from ICU within
48 h. Pneumonia in non-ventilated patients
was secondary outcome.
Yoneyama Pneumonia 21 184 34 182 Significant reduction (p < 0.05). 51 participants
excluded from analysis because they died from
causes other than pneumonia during follow-up.
Fatal pneumonia 14 184 30 182 Significant reduction (p < 0.05)
Bourigault Patients with pneumonia 93 868 203 1645 No difference
Fatal pneumonia 15 868 26 1645 No difference
Non-professional dental care
Chen Hospital acquired pneumonia 84 661 44 212 Significant reduction (p < 0.05)
McNally Hospital acquired pneumonia 25 1403 26 1487 No difference
Quinn Hospital acquired pneumonia Unclear Unclear Unclear Unclear Incidence decreased from 0.49 to 0.3 per 1000
patient days (38.8%).
Robertson Hospital acquired pneumonia 2 32 13 51 Significant reduction (p < 0.05)
Wagner Hospital acquired
pneumonia (post-stroke)
98 949 99 707 Significant reduction (p < 0.05)
Note: The raw numerator and denominator data from this study in the pre and post intervention phases are not able to be extracted from this study. No confident intervals are provided
around the incidence rates.
N
o
n
-ve
n
tila
to
r-a
sso
cia
te
d
h
o
sp
ita
l-a
cq
u
ire
d
p
n
e
u
m
o
n
ia
235
Mobility and NV-HAP prevention
We identified three studies that involved a form of physical
activity as a way of reducing the incidence of NV-HAP
[32e34]. Cuesy et al. conducted a randomised controlled
trial examining the effect of turning and passive mobi-
lisation on patients with acute ischemic stroke [33]. The
turn-mob program, instigated during the intervention
phase, included modifying the patient from supine position
to right and left lateral recumbent position every 2 h, in
addition to passive mobilizations of the 4 limbs through
each segment’s entire range of motion, every 6 h. Family
members were also involved in this process. The interven-
tion was associated with a decrease in NV-HAP (relative risk
of 0.39; 95% CI 0.19e0.79; P Z 0.008) [33]. A randomised
controlled trial undertaken by Boden et al. also reported a
reduction in NV-HAP [32]. The intervention included pre-
operative patient education, early ambulation and self-
directed breathing exercises, and additional pre-operative
physiotherapy. Although the primary outcome was post-
operative pulmonary complications, a reduction in NV-
HAP was also identified (HR 0.45; 95% CI 0.26e0.78,
P Z 0.005) [32]. Stolbrink et al. also undertook a
physiotherapy-based intervention that involved early
mobilisation in patients following a hip fracture [34]. In this
quasi-experimental study, the intervention was associated
with a lower incidence of NV-HAP (HR 0.39; 95% CI
0.22e0.68; P Z 0.001) [34].
Differences in NV-HAP definitions used in included
articles
The articles included in this review used different defini-
tions for determining cases of NV-HAP. These included chest
radiography with clinical symptoms of pneumonia [31e35],
Administrative coding data [14,38,39], Clinical Pulmonary
Infection Score [20], Centers for Disease Control and Pre-
vention (CDC) definition [29,36], and national professional
guidelines [20]. Some articles were less clear or did not
specify the diagnostic approach [28,30].
Discussion
In this review, interventions from studies aimed at reducing
NV-HAP, appear to be based broadly on the themes of
improving oral care, increased mobility or movement and
dysphagia management. The most common preventive
strategy used to reduce NV-HAP was oral care. The studies
included in our review focussed on improving oral care
through education, increasing frequency and or consistency
of oral care provided and use of an antiseptic. Further, the
highest quality studies evaluating the impact of improved
oral care all utilised professionals in the field of dentistry,
such as dentists and/or dental hygienists. However, while
most of these studies were randomised controlled trials,
they were largely conducted in residential aged care fa-
cilities, with only one randomised controlled study con-
ducted in a hospital setting. The feasibility of implementing
an intervention requiring dentistry input in a hospital
setting is limited at best. There are challenges in improving
the provision of oral care in the hospital setting. A recent
study illustrated this with an average of 1.6 tooth brushings
per day, when the goal of the intervention was three per
day by the nursing staff [38]. A recent review also identified
variation in the reported frequency of oral care provided by
nurses (range 2e3.5 times a day) and the documented
frequency of oral care in nursing notes (range 1.2e3.5
times a day) for non-ventilated patients [41]. Further, the
lack of nurse-led randomised studies for NV-HAP prevention
identified in this review highlights a critical issue for pa-
tient care. As nurses are primarily responsible for the daily
care needs of patients, they have a vital role to play in the
prevention of HAIs, including NV-HAP [42]. Three studies,
Quinn et al. [14], McNally et al. [38] and Robertson et al.
[20], all emphasised the importance of nurse-led initiatives
along with interdisciplinary collaboration as being vital to
successful oral care interventions. Improvements in oral
care are considered a modifiable risk factor for NV-HAP
[14,43].
The differing antiseptic agents used as part of oral care
interventions in the studies included in this review also
warrant discussion, as uncertainty remains regarding the
most appropriate antiseptic for oral care in the prevention
of NV-HAP. Antiseptic agents such as chlorhexidine gluco-
nate, sodium bicarbonate, hydrogen peroxide and cetyl-
pyridinium chloride are examples of antiseptics that were
used in the included studies. Povidone-iodine is also an
antiseptic agent known to be used for oral care in the
prevention of HAP in general [44]. Findings from our review
do not add to the existing evidence base regarding the use
of chlorhexidine gluconate in oral care for the prevention
of pneumonia in the literature [43,45e47]. Further
research on the effectiveness of chlorhexidine and other
antiseptics for oral care in HAP prevention has been called
for, including cost effectiveness analyses [43,46].
Our review also identified dysphagia screening and
physical activity or movement, as effective strategies for
preventing NV-HAP. This supports findings from a narrative
review of the literature by Pa´ssaro et al. [16], which also
showed a reduction in NV-HAP following the use of early
mobilization interventions as well as prompt diagnosis and
treatment of dysphagia. However, given the lack of studies
assessing these strategies in patients with NV-HAP (two
studies for dysphagia and three for physical activity) and
the lack of randomised control designs, their effectiveness
is uncertain, thus suggesting the need for further evalua-
tion of these strategies.
The diversity of interventions used for NV-HAP pre-
vention and settings makes comparisons, generalisability
and translation into practice difficult. In addition, the
small sample size of published studies [20,28] poses a
limitation to the generalisability of the findings. Hence,
the challenges in designing future NV-HAP intervention
studies include diagnoses, adequate sample sizes and
ethical considerations around accessing a high-risk pop-
ulation. As noted in our review, the methods used to
diagnose NV-HAP varied and included definitions from the
CDC guidelines [14], Association of Medical Microbiology
and Infectious Diseases Canada guidelines [20], clinical
symptoms and signs, and radiological features [31]. While
it is recognised that there is no gold standard for the
diagnosis of NV-HAP or VAP [47], we suggest that future
studies should use NV-HAP definitions from point
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prevalence studies, such as the European Centre for
Disease Prevention and Control [48]. The use of standard
definitions allows infection control and prevention pro-
fessionals and hospital epidemiologists to make sensible
comparisons among data from hospitals or against na-
tional data [42]. The use of definitions that are already
familiar from current use may also improve the reliability
of their application in studies.
While HAP is one of the most prevalent HAIs among
hospitalised patients, the incidence of NV-HAP in hospital-
ised patients is relatively low [11]. Hence, a large sample
size providing sufficient statistical power will be required
for any study seeking to determine the effects of NV-HAP
interventions. This large sample size, coupled with both
the need to undertake prospective diagnoses and diffi-
culties in implementing oral care interventions, presents a
major challenge. The incidence of NV-HAP is higher in high-
risk groups, such as the elderly or those with multiple co-
morbidities; therefore, studying this type of group may
aid a reduction in sample size. However, the challenge with
studying this type of group pertains to informed consent
and the associated selection bias. Therefore, a stepped
wedge design may be a useful study design for future NV-
HAP studies [49].
Our review has several limitations. The variability in
the definitions of NV-HAP and the substantial clinical and
methodological heterogeneity between the included
studies made it impossible to undertake a meta-analysis.
The quality and risk of bias of one-third of the studies
included in the review had ratings of five or less, and
therefore were considered to have a high risk of bias and
the potential to impact the study findings. In view of the
findings from this paper, it appears that improving the
quality and frequency of oral care, in addition to mobi-
lisation may be useful interventions in reducing the
incidence of NV-HAP. Nurse led randomised studies, to
assess the effectiveness of an intervention or in-
terventions to reduce the incidence of NV-HAP are
required. Such studies need to be rigorously conducted
and sufficiently powered.
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